Roivant Sciences (ROIV) Return on Sales (2020 - 2025)
Roivant Sciences (ROIV) reported Return on Sales of 0.19% for Q3 2025, up 29.0% on a YoY basis from 0.15% in Q3 2024, and up 58.07% quarter-over-quarter from 0.12% in Q2 2025.
Roivant Sciences (ROIV) Return on Sales (2020 - 2025) Analysis & Trends
Roivant Sciences has reported Return on Sales for 6 years, with the latest figure at 0.19% in Q3 2025.
- For the quarter ending Q3 2025, Return on Sales rose 29.0% year-over-year to 0.19%; the trailing twelve-month figure through Sep 2025 stood at 0.19% (up 19.0% YoY), and the FY2025 full-year result was 0.13%, up 22.0% from the prior year.
- Return on Sales for Q3 2025 stood at 0.19%, up from 0.12% in the prior quarter.
- The five-year high for Return on Sales was 0.36% in Q4 2024, with the low at 0.82% in Q2 2022.
- Historically, Return on Sales has averaged 0.1% across 5 years, with a median of 0.13% in 2021.
- Annual changes were most pronounced in 2022 — Return on Sales slumped 69 bps — and 2023, when it surged 67 bps.
- Roivant Sciences' Return on Sales stood at 0.13% in 2021, then sank by 79 bps to 0.23% in 2022, then jumped by 83 bps to 0.04% in 2023, then surged by 1068 bps to 0.36% in 2024, then plunged by 48 bps to 0.19% in 2025.
- The last three Return on Sales figures came in at 0.19% (Q3 2025), 0.12% (Q2 2025), and 0.36% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.19% |
| Jun 30, 2025 | 0.12% |
| Dec 31, 2024 | 0.36% |
| Sep 30, 2024 | -0.10% |
| Jun 30, 2024 | 0.11% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -0.24% |
| Jun 30, 2023 | -0.15% |
| Dec 31, 2022 | -0.23% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | -0.82% |
| Dec 31, 2021 | -0.13% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.13% |
| Dec 31, 2020 | -0.48% |
| Sep 30, 2020 | -0.40% |
| Jun 30, 2020 | -0.05% |